Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin vs Ciprofloxacin in Uncomplicated Skin Infections
NCT00257062Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jan 1993
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of levofloxacin in skin and skin structure infections (SSSIs) (2 arms), sponsored by Johnson & Johnson. Primary endpoints: Clinical response rate at post-therapy, Microbiological response at post-therapy and 1 more. Started Jan 1993; status: completed.
02
Drugs
levofloxacin
03
Conditions
skin and skin structure infections (SSSIs)
Beyond the preview
Go deeper on NCT00257062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257062.